Key terms

About ALB

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, Ketjen, and All Other. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The All Other segment refers only to the FCS business that did not fit into any of the company’s core businesses. The company was founded in 1993 and is headquartered in Charlotte, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ALB news

Apr 12 10:36am ET Albemarle put volume heavy and directionally bearish Apr 11 4:25am ET Albemarle upgraded to Buy from Hold at Berenberg Apr 08 8:31am ET Wall Street Analysts Are Bullish on Top Materials Picks Apr 04 4:55am ET Albemarle management to meet with Oppenheimer Apr 03 4:04pm ET Albemarle management to meet with Oppenheimer Apr 01 10:16am ET Albemarle put volume heavy and directionally bearish Mar 28 8:57am ET Lithium stocks jumped after high Albemarle auction prices, says Loop Capital Mar 27 9:56am ET Early notable gainers among liquid option names on March 27th Mar 15 9:20am ET Albemarle price target lowered to $162 from $168 at Loop Capital Mar 11 9:55am ET Early notable gainers among liquid option names on March 11th Mar 11 7:03am ET Albemarle price target lowered to $81 from $90 at Morgan Stanley Mar 11 6:05am ET Albemarle’s Growth and Dilution Concerns Prompt Sell Rating and Lowered Price Target Mar 08 7:48am ET Albemarle downgraded to Hold from Buy at Vertical Research Mar 07 6:36am ET Albemarle price target lowered to $112 from $115 at Mizuho Mar 07 6:33am ET Albemarle price target lowered to $159 from $178 at KeyBanc Mar 05 12:00pm ET Albemarle falls -11.7% Mar 05 10:00am ET Albemarle falls -12.7% Mar 05 9:16am ET Albermarle (NYSE:ALB) Sinks on $1.75B Public Offering of Depository Shares Mar 05 7:35am ET TD Cowen Remains a Hold on Albemarle (ALB) Mar 05 5:55am ET Albemarle management to meet with Oppenheimer Mar 05 5:08am ET Analysts Conflicted on These Materials Names: James Hardie (OtherJHIUF), Tecnoglass (TGLS) and Albemarle (ALB) Mar 05 4:26am ET Albemarle’s Strategic Financial Moves Prompt Buy Rating Amid Growth Projects and Balance Sheet Strengthening Mar 04 4:16pm ET Albemarle announces $1.75B depositary shares offering Mar 04 9:35am ET Albemarle price target raised to $168 from $144 at Loop Capital Mar 04 4:55am ET Albemarle management to meet with Oppenheimer Mar 01 9:46am ET GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls Mar 01 7:51am ET Albemarle management to meet with Oppenheimer Feb 29 6:26pm ET Albemarle initiated with a Peer Perform at Wolfe Research Feb 29 4:34pm ET Albemarle initiated with a Peer Perform at Wolfe Research Feb 29 9:55am ET Early notable gainers among liquid option names on February 29th Feb 27 9:55am ET Early notable gainers among liquid option names on February 27th

No recent press releases are available for ALB

ALB Financials

1-year income & revenue

Key terms

ALB Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ALB Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms